Johnson Matthey (OTCMKTS:JMPLY) PT Lowered to GBX 1,900

Johnson Matthey (OTCMKTS:JMPLYGet Rating) had its price target cut by analysts at Barclays from GBX 2,110 ($25.50) to GBX 1,900 ($22.96) in a report issued on Wednesday, The Fly reports.

A number of other equities analysts also recently issued reports on the stock. HSBC downgraded shares of Johnson Matthey from a “buy” rating to a “hold” rating in a research note on Monday, June 6th. Panmure Gordon upgraded shares of Johnson Matthey from a “hold” rating to a “buy” rating in a report on Wednesday, June 8th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $2,320.00.

Johnson Matthey Price Performance

JMPLY stock opened at $42.93 on Wednesday. Johnson Matthey has a 1 year low of $42.72 and a 1 year high of $77.97. The firm has a 50-day moving average of $49.98 and a 200 day moving average of $51.04. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.33 and a quick ratio of 0.84.

Johnson Matthey Company Profile

(Get Rating)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Stories

The Fly logo

Analyst Recommendations for Johnson Matthey (OTCMKTS:JMPLY)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.